NCT05760534CompletedPhase 4
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia - a Phase 4 Clinical Trial
Source: ClinicalTrials.gov · Last updated 29 Dec 2025
Brief summary (registry, in English)
This study aims to compare ideal body weight- and total body weight-based dosage for remimazolam sedation of obese patients undergoing knee or hip arthroplasty under spinal anesthesia.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (actual)
- First submitted
- 26 Feb 2023
- Start date
- 6 Mar 2023
- Primary completion date
- 25 Nov 2025
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Obesity
- NCT number
- NCT05760534
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 110
- From 6 Mar 2023 to the primary completion date, 25 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of hypersensitivity to remimazolam
- History of chronic use of benzodiazepine or opioid
Other
- Patient refusal
- Contraindication for spinal anesthesia
- Contraindication for remimazolam infusion
- Baseline MOAA/S score of 4 or lower
- Pregnancy
Who the study is looking for
- Patients scheduled for elective knee or hip arthroplasty under spinal anesthesia
- BMI\>25
- American Society of Anesthesiologists (ASA) classification I, II, III
Age in the registry: 19 years to 79 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jin-Tae Kim Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.